Wave Life Sciences Ltd. financial data

Symbol
WVE on Nasdaq
Industry
Pharmaceutical Preparations
Location
7 Straits View, #12 00, Marina One East Tower, Singapore, Singapore
State of incorporation
Singapore
Fiscal year end
December 31
Former names
Wave Life Sciences Pte Ltd (to 11/2/2015)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 133 % -10.4%
Debt-to-equity 415 %
Return On Equity -281 % -242%
Return On Assets -52.9 % -31.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 153M shares +54%
Common Stock, Shares, Outstanding 148M shares +49.9%
Entity Public Float 259M USD +26%
Common Stock, Value, Issued 1.14B USD +35.5%
Weighted Average Number of Shares Outstanding, Basic 133M shares +25%
Weighted Average Number of Shares Outstanding, Diluted 133M shares +23.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 111M USD +202%
Research and Development Expense 149M USD +17.4%
General and Administrative Expense 56.6M USD +10.1%
Operating Income (Loss) -152M USD -63.7%
Nonoperating Income (Expense) 9.54M USD +20.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -143M USD -67.7%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -143M USD -67.7%
Earnings Per Share, Basic -1.1 USD/shares -39.2%
Earnings Per Share, Diluted -1.1 USD/shares -39.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 311M USD +122%
Cash, Cash Equivalents, and Short-term Investments 122M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 3M USD -27.2%
Assets, Current 325M USD +105%
Property, Plant and Equipment, Net 10.9M USD -20.6%
Operating Lease, Right-of-Use Asset 19.1M USD -19.5%
Assets 359M USD +79.3%
Accounts Payable, Current 12.8M USD +1.37%
Employee-related Liabilities, Current 9.74M USD +15.1%
Accrued Liabilities, Current 2.83M USD -8.28%
Contract with Customer, Liability, Current 136M USD +99.1%
Liabilities, Current 171M USD +70.8%
Contract with Customer, Liability, Noncurrent 18.5M USD -82.5%
Operating Lease, Liability, Noncurrent 19.8M USD -27.2%
Other Liabilities, Noncurrent 190K USD
Liabilities 209M USD -10.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -159K USD +12.6%
Retained Earnings (Accumulated Deficit) -1.15B USD -14.1%
Stockholders' Equity Attributable to Parent 142M USD
Liabilities and Equity 359M USD +79.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.4M USD -139%
Net Cash Provided by (Used in) Financing Activities 14.5M USD -58.6%
Net Cash Provided by (Used in) Investing Activities -417K USD +14.7%
Common Stock, Shares, Issued 148M shares +49.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -19.4M USD -116%
Deferred Tax Assets, Valuation Allowance 247M USD +9.25%
Deferred Tax Assets, Gross 253M USD +8.42%
Operating Lease, Liability 32.1M USD -14.6%
Depreciation 1.04M USD -27.3%
Payments to Acquire Property, Plant, and Equipment 417K USD -14.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -142M USD -67.6%
Lessee, Operating Lease, Liability, to be Paid 38.4M USD -18.4%
Property, Plant and Equipment, Gross 55.8M USD +1.2%
Operating Lease, Liability, Current 7.4M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.59M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.31M USD +7.58%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.24M USD -33.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.58M USD -0.07%
Deferred Tax Assets, Operating Loss Carryforwards 173M USD +8.92%
Unrecognized Tax Benefits 15.8M USD +13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.99M USD -6.23%
Additional Paid in Capital 153M USD +20.7%
Deferred Tax Assets, Net of Valuation Allowance 6.19M USD -16.6%
Share-based Payment Arrangement, Expense 2.88M USD +4.76%